News

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.
Guillain-Barre is normally rare, with about 1.1 cases per 100,000 people in Europe and North America. According to the new study, that rate climbed to 24 cases per 100,000 during the French ...
People Editorial Guidelines Published on January 11, 2022 12:58PM EST Jenna Jameson gave an update on her health on Tuesday, clarifying that her likely case of Guillain-Barré Syndrome is "NOT a ...
Lewis was an active young boy who loved playing football and swimming. Even after getting a pain in his leg which persisted for a week, blood tests with the GP suggested this could be simply growing ...
Guillain-Barre syndrome has gained attention due to a possible link with COVID-19. Experts what the disease is as well as causes, ... Now many people are curious about this condition, ...
The chances of developing Guillain-Barré Syndrome (GBS) from the Johnson & Johnson Covid-19 vaccine are small. Here's what you need to know.
A haywire immune system, attacking healthy nerves, causes the disorder. U.S. health authorities added a warning to the label of J&J’s Covid-19 vaccine after finding 100 reports.
Although Guillain-Barré syndrome can be life-threatening, most people recover with few remaining complications. An exact cause of the condition is unknown, but it can arise after gastrointestinal ...
Health officials have estimated about two cases of Guillain-Barre syndrome in every 1 million people who receive the RSV vaccine within three weeks of getting the shot. Sign up for the Breaking ...
Pune authorities are investigating 22 suspected cases of Guillain-Barré syndrome (GBS), a rare neurological disorder, mainly affecting people aged 12 to 30. While the cases are spread across ...
An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more common in older ...
An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more common in older ...